Séchaud, R, Dutreix, C, Balez, S, Pommier, F, Dumortier, T, Morisson, S and Brun, E (2008) Relative bioavailability of deferasirox tablets administered without dispersion and dispersed in various drinks. International journal of clinical pharmacology and therapeutics, 46 (2). pp. 102-108. ISSN 0946-1965

Abstract

Deferasirox (ExjadeA, ICL670) is a new, once-daily oral iron chelator, recently approved as first-line therapy in the treatment of iron overload resulting from blood transfusions. In registration studies, deferasirox tablets were dispersed in non-carbonated water prior to administration. In routine clinical practice, however, patients may prefer to take the tablet dispersed in a flavored drink rather than with water.

Item Type:	Article
Date Deposited:	28 Jan 2012 00:45
Last Modified:	28 Jan 2012 00:45
URI:	https://oak.novartis.com/id/eprint/5518